ARK Investment Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.8M | Sell |
4,016,485
-3,716,085
| -48% | -$43.3M | 0.34% | 48 |
|
|
2025
Q1 | $57.5M | Sell |
7,732,570
-1,691,504
| -18% | -$12.6M | 0.58% | 36 |
|
|
2024
Q4 | $56.5M | Sell |
9,424,074
-2,177,060
| -19% | -$13.1M | 0.47% | 38 |
|
|
2024
Q3 | $59.4M | Buy |
11,601,134
+189,134
| +2% | +$968K | 0.54% | 35 |
|
|
2024
Q2 | $41.3M | Buy |
11,412,000
+850,704
| +8% | +$3.08M | 0.37% | 46 |
|
|
2024
Q1 | $33.9M | Sell |
10,561,296
-2,245,217
| -18% | -$7.21M | 0.23% | 63 |
|
|
2023
Q4 | $62.8M | Buy |
12,806,513
+1,297,205
| +11% | +$6.36M | 0.37% | 41 |
|
|
2023
Q3 | $62.7M | Buy |
11,509,308
+1,055,556
| +10% | +$5.75M | 0.48% | 37 |
|
|
2023
Q2 | $70.1M | Buy |
10,453,752
+1,248,627
| +14% | +$8.38M | 0.46% | 35 |
|
|
2023
Q1 | $81.3M | Buy |
9,205,125
+3,880
| +0% | +$34.3K | 0.56% | 32 |
|
|
2022
Q4 | $70.3M | Sell |
9,201,245
-135,374
| -1% | -$1.03M | 0.61% | 33 |
|
|
2022
Q3 | $66.5M | Buy |
9,336,619
+563,601
| +6% | +$4.01M | 0.46% | 40 |
|
|
2022
Q2 | $68.6M | Buy |
8,773,018
+1,063,352
| +14% | +$8.32M | 0.41% | 46 |
|
|
2022
Q1 | $107M | Buy |
7,709,666
+2,011,798
| +35% | +$27.9M | 0.45% | 40 |
|
|
2021
Q4 | $160M | Buy |
5,697,868
+841,447
| +17% | +$23.6M | 0.48% | 42 |
|
|
2021
Q3 | $165M | Buy |
4,856,421
+489,444
| +11% | +$16.6M | 0.4% | 53 |
|
|
2021
Q2 | $178M | Buy |
4,366,977
+893,067
| +26% | +$36.5M | 0.33% | 66 |
|
|
2021
Q1 | $140M | Buy |
3,473,910
+1,928,207
| +125% | +$77.6M | 0.28% | 74 |
|
|
2020
Q4 | $91.4M | Buy |
1,545,703
+660,981
| +75% | +$39.1M | 0.24% | 75 |
|
|
2020
Q3 | $43M | Buy |
884,722
+575,584
| +186% | +$28M | 0.26% | 61 |
|
|
2020
Q2 | $15M | Buy |
+309,138
| New | +$15M | 0.16% | 70 |
|